BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 19095069)

  • 1. Real-time MR imaging of adeno-associated viral vector delivery to the primate brain.
    Fiandaca MS; Varenika V; Eberling J; McKnight T; Bringas J; Pivirotto P; Beyer J; Hadaczek P; Bowers W; Park J; Federoff H; Forsayeth J; Bankiewicz KS
    Neuroimage; 2009 Aug; 47 Suppl 2(Suppl 2):T27-35. PubMed ID: 19095069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodistribution of adeno-associated virus type-2 in nonhuman primates after convection-enhanced delivery to brain.
    Cunningham J; Pivirotto P; Bringas J; Suzuki B; Vijay S; Sanftner L; Kitamura M; Chan C; Bankiewicz KS
    Mol Ther; 2008 Jul; 16(7):1267-75. PubMed ID: 18523450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T2 imaging in monitoring of intraparenchymal real-time convection-enhanced delivery.
    Richardson RM; Gimenez F; Salegio EA; Su X; Bringas J; Berger MS; Bankiewicz KS
    Neurosurgery; 2011 Jul; 69(1):154-63; discussion 163. PubMed ID: 21430597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AAV2-mediated gene delivery to monkey putamen: evaluation of an infusion device and delivery parameters.
    Sanftner LM; Sommer JM; Suzuki BM; Smith PH; Vijay S; Vargas JA; Forsayeth JR; Cunningham J; Bankiewicz KS; Kao H; Bernal J; Pierce GF; Johnson KW
    Exp Neurol; 2005 Aug; 194(2):476-83. PubMed ID: 16022872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Convection-enhanced delivery of adeno-associated virus type 2 (AAV2) into the striatum and transport of AAV2 within monkey brain.
    Hadaczek P; Kohutnicka M; Krauze MT; Bringas J; Pivirotto P; Cunningham J; Bankiewicz K
    Hum Gene Ther; 2006 Mar; 17(3):291-302. PubMed ID: 16544978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-time MR imaging with Gadoteridol predicts distribution of transgenes after convection-enhanced delivery of AAV2 vectors.
    Su X; Kells AP; Salegio EA; Salegio EA; Richardson RM; Hadaczek P; Beyer J; Bringas J; Pivirotto P; Forsayeth J; Bankiewicz KS
    Mol Ther; 2010 Aug; 18(8):1490-5. PubMed ID: 20551915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adeno-associated virus type 6 is retrogradely transported in the non-human primate brain.
    San Sebastian W; Samaranch L; Heller G; Kells AP; Bringas J; Pivirotto P; Forsayeth J; Bankiewicz KS
    Gene Ther; 2013 Dec; 20(12):1178-83. PubMed ID: 24067867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbidopa-based modulation of the functional effect of the AAV2-hAADC gene therapy in 6-OHDA lesioned rats.
    Ciesielska A; Sharma N; Beyer J; Forsayeth J; Bankiewicz K
    PLoS One; 2015; 10(4):e0122708. PubMed ID: 25860990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and tolerability of magnetic resonance imaging-guided convection-enhanced delivery of AAV2-hAADC with a novel delivery platform in nonhuman primate striatum.
    San Sebastian W; Richardson RM; Kells AP; Lamarre C; Bringas J; Pivirotto P; Salegio EA; Dearmond SJ; Forsayeth J; Bankiewicz KS
    Hum Gene Ther; 2012 Feb; 23(2):210-7. PubMed ID: 22017504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eight years of clinical improvement in MPTP-lesioned primates after gene therapy with AAV2-hAADC.
    Hadaczek P; Eberling JL; Pivirotto P; Bringas J; Forsayeth J; Bankiewicz KS
    Mol Ther; 2010 Aug; 18(8):1458-61. PubMed ID: 20531394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depletion of AADC activity in caudate nucleus and putamen of Parkinson's disease patients; implications for ongoing AAV2-AADC gene therapy trial.
    Ciesielska A; Samaranch L; San Sebastian W; Dickson DW; Goldman S; Forsayeth J; Bankiewicz KS
    PLoS One; 2017; 12(2):e0169965. PubMed ID: 28166239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Widespread optogenetic expression in macaque cortex obtained with MR-guided, convection enhanced delivery (CED) of AAV vector to the thalamus.
    Yazdan-Shahmorad A; Tian N; Kharazia V; Samaranch L; Kells A; Bringas J; He J; Bankiewicz K; Sabes PN
    J Neurosci Methods; 2018 Jan; 293():347-358. PubMed ID: 29042259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy for aromatic L-amino acid decarboxylase deficiency by MR-guided direct delivery of AAV2-AADC to midbrain dopaminergic neurons.
    Pearson TS; Gupta N; San Sebastian W; Imamura-Ching J; Viehoever A; Grijalvo-Perez A; Fay AJ; Seth N; Lundy SM; Seo Y; Pampaloni M; Hyland K; Smith E; de Oliveira Barbosa G; Heathcock JC; Minnema A; Lonser R; Elder JB; Leonard J; Larson P; Bankiewicz KS
    Nat Commun; 2021 Jul; 12(1):4251. PubMed ID: 34253733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gadolinium-loaded liposomes allow for real-time magnetic resonance imaging of convection-enhanced delivery in the primate brain.
    Saito R; Krauze MT; Bringas JR; Noble C; McKnight TR; Jackson P; Wendland MF; Mamot C; Drummond DC; Kirpotin DB; Hong K; Berger MS; Park JW; Bankiewicz KS
    Exp Neurol; 2005 Dec; 196(2):381-9. PubMed ID: 16197944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Convection-enhanced delivery of AAV vector in parkinsonian monkeys; in vivo detection of gene expression and restoration of dopaminergic function using pro-drug approach.
    Bankiewicz KS; Eberling JL; Kohutnicka M; Jagust W; Pivirotto P; Bringas J; Cunningham J; Budinger TF; Harvey-White J
    Exp Neurol; 2000 Jul; 164(1):2-14. PubMed ID: 10877910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dose-ranging study of AAV-hAADC therapy in Parkinsonian monkeys.
    Forsayeth JR; Eberling JL; Sanftner LM; Zhen Z; Pivirotto P; Bringas J; Cunningham J; Bankiewicz KS
    Mol Ther; 2006 Oct; 14(4):571-7. PubMed ID: 16781894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term clinical improvement in MPTP-lesioned primates after gene therapy with AAV-hAADC.
    Bankiewicz KS; Forsayeth J; Eberling JL; Sanchez-Pernaute R; Pivirotto P; Bringas J; Herscovitch P; Carson RE; Eckelman W; Reutter B; Cunningham J
    Mol Ther; 2006 Oct; 14(4):564-70. PubMed ID: 16829205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of AAV2-hAADC-transduced cells after 3 years in Parkinsonian monkeys.
    Daadi MM; Pivirotto P; Bringas J; Cunningham J; Forsayeth J; Eberling J; Bankiewicz KS
    Neuroreport; 2006 Feb; 17(2):201-4. PubMed ID: 16407771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant adeno-associated virus type 2 pseudotypes: comparing safety, specificity, and transduction efficiency in the primate striatum. Laboratory investigation.
    Sanchez CE; Tierney TS; Gale JT; Alavian KN; Sahin A; Lee JS; Mulligan RC; Carter BS
    J Neurosurg; 2011 Mar; 114(3):672-80. PubMed ID: 20950087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Qualitative imaging of adeno-associated virus serotype 2-human aromatic L-amino acid decarboxylase gene therapy in a phase I study for the treatment of Parkinson disease.
    Valles F; Fiandaca MS; Eberling JL; Starr PA; Larson PS; Christine CW; Forsayeth J; Richardson RM; Su X; Aminoff MJ; Bankiewicz KS
    Neurosurgery; 2010 Nov; 67(5):1377-85. PubMed ID: 20871425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.